Monday 30 January 2023
Friday 27 January 2023
Thursday 26 January 2023
Wednesday 25 January 2023
Monday 23 January 2023
Tuesday 17 January 2023
Investor Ideas #Cannabis #Potcasts 643: Interview with CEO of Tilt Holdings Inc. (OTC: $TLLTF) (NEO: TILT)
Investor Ideas #Cannabis #Potcasts 643: Interview with CEO of Tilt Holdings Inc. (OTC: $TLLTF) (NEO: TILT)
Delta, Kelowna, BC, January 17, 2023 (Investorideas.com Newswire), investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2023/011723-Cannabis.mp3
Read this in full at https://www.investorideas.com/news/2023/cannabis-potcasts/01171Interview-TLLTF.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
In today’s podcast Investorideas interviews Gary Santo, CEO of Tilt Holdings Inc. (OTC: TLLTF) (NEO:TILT), where we discussed some of the companies recent news, their 2022 year and how this leads into expectations for 2023, what to look for in brand partnerships as well as how the US market is developing over all.
Just last week the company announced that its Chief Executive Officer Gary Santo has been appointed to the Board of Directors of the National Cannabis Roundtable (“NCR”). Founded in 2019, NCR is a non-partisan alliance of cannabis companies and ancillary services and solutions providers working to advance cannabis policy in the United States.
“The National Cannabis Roundtable has been and continues to be at the forefront of federal cannabis policy,” said Gary Santo, TILT’s CEO. “While the industry made some important gains, including a presidential pardon of all federal convictions for simple possession of marijuana and the review of the scheduling of cannabis under federal law, unfortunately, the SAFE Banking Act failed to pass Congress. The failure of the SAFE Banking Act to pass the Senate shows once again there is still more work to be done. As a member of the NCR, TILT will continue to advocate for access to traditional financial services and capital markets for cannabis businesses, as well as the elimination of tax barriers such as 280E.”
Continued Santo, “TILT will fully support NCR’s legislative priorities around decriminalising cannabis, maintaining business continuity, ensuring consumer and worker safety, promoting social equity, and remediating harms from prohibition.”
Santo joined Tilt Holdings in mid 2020, at the height of COVID, after spending time at Columbia Care Inc. (OTC:CCHWF) which he later helped take public, and prior to that his background was in Finance, Healthcare, Life Sciences and Casino Gaming Equipment.
When asked about what brought him specifically to Tilt, Santo commented, “Tilt really was a tremendous platform. We are in a number of states, Massachusetts, Pennsylvania and Ohio, we have a partnership in New York as well as an entire part of the business that doesn’t touch the plant out in Arizona, Jupiter Research, our hardware division, where we provide batteries and cartridges for cannabis vaping. So we are truly an end to end provider on a business to business front and I think it puts us in a very unique position in a crowded market right now.”
Jupiter Research, LLC announced back in November that it had entered into an agreement with House of Blends Inc. to distribute the Blend Pen™ by Aiden™ in the United States and Canada.
Aiden’s patent-pending Blend Pen™ breaks the standard vape mould by holding two cartridges, side-by-side, within the pen. Each cartridge has adjustable power outputs, allowing consumers to become their own cannabis mixologists, by creating unique THC to CBD blends or combining strains to create their hybrid mixes. Blend Pen™ by Aiden™ also has an accompanying app in development to track and personalise the consumption experience based on usage information. It’s anticipated to be in the market for early 2023.
When asked about how the current cannabis vaping market and how it was affected by the Pandemic, Santo commented “when people were no longer having to go into the office, the utility that a vape provides, being able to step outside the building and take a quick pull and go back, you suddenly didn’t need that anymore. When the utility dropped away we saw every percentage point for vaping went down and smokeable flower went up. As we’ve seen a return to the workplace we’ve seen a return of those all in ones, but we’ve also noticed a change in the consumer in what they’re trying to vape. Before you had a lot of those flowery and fruit flavours, but we saw from people smoking the flower a return to the natural terpenes. So while traditional distillate continues to be a major part of the vaping industry, we are seeing a movement to less viscous forms, the waxes, the shatters the butters, that requires a different technology then what you would use in higher viscosity vaping. That’s where Jupiter is really at its sweet spot. We distribute C-Cell which uses a ceramic centre atomizer wrapper with a cotton wick, which provides much more even heating. We just rolled out three new technologies at MJBiz that are leaning now towards things like blending, things like less viscous forms of vaporisation where more natural terpenes are coming into play. I think what we are seeing is its starting to bifurcate into those who will stay with the high viscosity distillate and those who are moving into less viscous, more pure forms that feel more like you’re smoking the actual flower.”
When asked about the company’s position on brand partnerships and developments, Santo commented, “we have partnered with brands, so we are not buying them and becoming a house of brands that we own. We tend to stay away from things like Celebrity Weed or brands without a lot of depth. If we guess wrong, we are asset light in that mix so it just means that we will find another brand that will fit that same product grid and switch to that brand. We aren’t millions of dollars invested into a brand architecture we might have to reinvent. I think it's an interesting way to balance all the price compression you see and the wholesale noise you hear about.”
Tilt announced back in November that it will launch a cannabis product brand with its partner the Shinnecock Indian Nation, to introduce Little Beach Harvest’s ancestral plant medicine to Massachusetts. Joining the TILT brand partner portfolio is in addition to the Shinnecock Nation’s main collaborative effort with TILT: developing cannabis operations known by the same name, Little Beach Harvest, on sovereign Shinnecock Nation land in Southampton, NY.
The established partnership between TILT and the Shinnecock Nation is an integral component of the product line’s development, with members of the tribal nation joining TILT’s award-winning cultivation team in overseeing strain selection and product direction. From seed-to-sale, both the Little Beach Harvest dispensary and branded product line draw on the Shinnecock Nation’s centuries-long knowledge of plant medicines and natural healing modalities. The initial market release will be focused on flower with additional categories expected to launch throughout 2023. All products will feature a variation of Little Beach Harvest’s newly established brand look, which includes visual cues and colours inherently connected with the Shinnecock Nation.
“Little Beach Harvest naturally fits in TILT’s brand partner portfolio, especially given the Shinnecock Nation’s ancestral medicinal cannabis connection. We have a purpose-driven opportunity to bring Indigenous cannabis onto the same stage as Highsman, Her Highness and Old Pal while also creating a positive impact for a community historically excluded from and by the cannabis market,” stated TILT’s Senior Vice President of Marketing and Communications, Amy Larson. “Introducing the Little Beach Harvest brand beyond New York to other northeast states increases awareness of the part Indigenous communities are playing in the cannabis industry.”
TILT and the Shinnecock Nation announced their partnership in 2021 to create a fully vertical operation on tribal land that is wholly owned by the Shinnecock Nation. Funding and business management services are provided by TILT. Groundbreaking of the dispensary took place in July 2022 and is anticipated to open in early 2023. The 5,000-square-foot dispensary will be along the main Southampton roadway and will feature drive-through service.
Speaking on the difference between Tilt’s 2022 year and expectations for 2023, Santo commented “I think for 2023, people are cautiously optimistic. When you go back to 2022 analysts were predicting the usual growth of 30% and then slowly adjusted. I do think we have gotten so accustomed to ridiculously explosive growth. It was the only industry I ever saw where people looked at 30% growth and considered you a laggard. That’s not sustainable. I do think that the problem with the Investor sentiment is still investor access. This is a high growth industry. It’s specialty agriculture, specialty manufacturing and specialty retail all squeezed together into one industry with regulations differing from State to State. You have to have the right kind of investor base, not the retail investor. Unfortunately how this market was launched paired up retail investors with a high growth stock. The amount of capital that was raised was incredible to me. People were trading on emotion not on the fundamentals. I’m hoping we can make it a little easier for people to invest and find capital in the industry.
Santo also discussed the company’s recent news that the company retired US $7.5 million of its secured promissory notes in the fourth quarter and entered into amendments to the remaining senior secured promissory notes held by certain senior noteholders totaling US $2.1 million to extend the maturity dates of such notes from December 31, 2022 to February 28, 2023. With the payments, the Company has successfully retired approximately US $33.7 million of the US $35.8 million principal of senior secured notes that were originally scheduled to mature in November 2022.
The Company has also signed a fifth amendment to its previously announced definitive agreement with Innovative Industrial Properties, Inc. (“IIPR”) to sell and leaseback its White Haven, Pennsylvania facility. With all other matters for the property already satisfied, the Amendment allows TILT and IIPR to extend the end of the investigational period of the transaction contemplated to a date that is on or before February 28, 2023, to coincide with the new debt facility.
“We continue to be opportunistic in our approach to addressing our legacy debt maturities as well as improving our liquidity position. TILT has had to overcome challenging market conditions to obtain US $40M in non-dilutive capital earlier this year, which along with available cash on hand has resulted in retiring 94% of our legacy senior debt,” said TILT’s Chief Executive Officer, Gary Santo. “At the same time, we have continued to make excellent progress with new and existing investors in our efforts to finalise the terms of the refinancing of our remaining legacy debt.”
Santo went on to discuss the current pricing issues being faced within the industry, where the industry stock prices are now and where they could be over the next couple of years, how the cannabis industry has compared to other industries over the last three years as well as what Tilt has on the horizon for 2023 and beyond.
To find out more information about Tilt Holdings click the link here.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) , Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio , Google Podcasts and most audio platforms available.
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com publishes breaking stock news, third party stock research , guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast , Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and the AI Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Friday 13 January 2023
Thursday 12 January 2023
Wednesday 11 January 2023
Friday 6 January 2023
Investor Ideas #Potcasts 642, #Cannabis News and #Stocks on the Move-(TSXV: $KHRN.V) (OTCQX: $KHRNF) (NASDAQ: $VFF)
Investor Ideas #Potcasts 642, #Cannabis News and #Stocks on the Move-(TSXV: $KHRN.V) (OTCQX: $KHRNF) (NASDAQ: $VFF)
Delta, Kelowna, BC, January 6th, 2023 (Investorideas.com Newswire), investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2023/010623-Cannabis.mp3
Read this in full at https://www.investorideas.com/news/2023/cannabis-potcasts/01061KHRN-VFF.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
In today’s podcast we look at a few public company announcements, how the overall price of cannabis is becoming an issue for the industry as well as how legalisation continues to impact cannabis culture.
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) announced that the new Colombian Government has included plant-based medical cannabis products (i.e., Khiron products) in the list of mandatory insurance-covered medications starting January 1st, 2023, as well as the signing of a first-of-its-kind medical cannabis contract with one of Colombia's largest insurance companies based in the city of Bogota.
Resolution 2808 of 2022 was signed by the Ministry of Health on December 30, 2022. This revision was necessary to remove unintended ambiguities that had arisen whether plant-based magistral preparations from medical cannabis (i.e., Khiron products) were also included in the insurance coverage. This is now once and for all clearly confirmed. The new government is fully committed with the use of medical cannabis as a covered treatment under the Colombian health system.
The Government used this iteration to also validate medical conditions where they find moderate to strong evidence that cannabis is an effective treatment. These medical conditions evaluated by the IETS (Technical Institute of the health Sector) include chronic and neuropathic pain, oncology pain, sleep disorders, epilepsy, and fibromyalgia, which represent the primary conditions treated with Khiron products.
During the first half of 2022, insurance-covered prescriptions represented more than 90% of the Company´s cannabis sales in Colombia. With a patient base of more than 25,000 patients, Khiron will immediately resume filling insurance-covered prescriptions through its Zerenia clinic network.
In addition, Zerenia™ Colombia (Khiron´s wholly owned medical cannabis clinic network), has entered into a contract to provide "Integrative Health Services and Pharmacotherapeutic Treatment with Medical Cannabis" with the largest Government-owned insurance company in the city of Bogota, with more than 1.2 million insured individuals. This is the first time an insurance company in Latin America is contracting medical cannabis specific services and products. This represents an opportunity for Khiron and Zerenia to expand its client and patient base within Colombia, while continuing to differentiate itself with its unparalleled expertise in medical cannabis and proprietary scientific evidence.
Alvaro Torres, CEO of Khiron, comments: "Today is a great day for patients in Colombia and Khiron. We welcome the decision from the new Colombian government to categorically mandate insurance coverage for our medical cannabis products. With this decision, Khiron will immediately tackle the backlog of covered medical cannabis products to our patients. In parallel, we have also secured a first-of-its-kind contractual relationship with one of Colombia´s largest government-owned insurance companies for medical cannabis specific healthcare services and dispensation. These two achievements, will allow us to revert to predictable recurring revenues, shorter collection periods and improved cash flow."
Village Farms International, Inc. (NASDAQ: VFF) announced further progress on its international cannabis strategy, and commented that the lack of cannabis legislative action by the United States Senate (in direct contrast to the 39 States / the District of Columbia with legally sanctioned medical-use and/or adult-use THC, as well as the vast majority of United States' citizens) while disappointing, does not impact Village Farms' plans to leverage its considerable success in Canada into other cannabis markets with greater regulatory support. Recently, the Company's Canadian Cannabis business, through its subsidiary, Pure Sunfarms, commenced shipping cannabis products for the Israeli medical market under an exclusive three-year supply agreement with Israel-based Dr. Samuelov Importing and Marketing Ltd., doing business as Better Pharma.
Founded in the early 1990s, Better Pharma is a highly respected importer of pharmaceuticals and related products for the Israeli market with longstanding relationships with Israel's retail pharmacies and an extensive sales force and distribution capabilities, covering over 95% of Israeli independent pharmacies, as well as retail drug stores.
"Commencing shipments to Israel is another milestone in our global cannabis strategy, building on our successes in Canada and Australia," said Michael DeGiglio, Chief Executive Officer, Village Farms. "We are proud and privileged to partner exclusively with Better Pharma for the significant medical cannabis opportunity in Israel and are confident that Pure Sunfarms unique "Everyday Premium" positioning, which has proven so successful in Canada and Australia, will be differentiated in the Israeli market, and well-received by patients."
"Our agreement with Better Pharma marks the first time Pure Sunfarms branded flower, inclusive of Canada's top-selling Pink Kush, makes its way to consumers internationally," said Mandesh Dosanjh, President and CEO, Pure Sunfarms. "We're confident that Better Pharma, an organisation that shares our belief in a brand-led consumer approach, will help patients in Israel come to know and appreciate Pure Sunfarms high-quality, BC grown strains as much as Canadians have."
"We are proud and honoured to exclusively partner with Pure Sunfarms, Canada's No.1 flower brand and market leader, for medical cannabis products," said Ran Samuelov, Chief Executive Officer, Better Pharma. "We are confident we will be able to leverage our knowledge and expertise in international brand management for Pure Sunfarms to become one of the leading medical cannabis brands in Israel. We are looking forward to delivering Pure Sunfarms unique and differentiated "Everyday Premium" brand proposition to Israeli medical patients and pharmacists."
Sales of Pure Sunfarms product to patients in Israel are expected to commence later this month. Initial strains offered will include Pink Kush, Jet Fuel Gelato, and Sakura Punch (sold as Black Cherry Punch in Canada).
Village Farms continues to execute on its global cannabis strategy, which includes accelerated sales to the Australian medical market and plans to launch in the German medical market.
In a recent Bloomberg article titled, Cheap Weed Has Become a Big Problem in the Pot Industry, the overall price of cannabis is implied to be a growing issue for both the legal and legacy markets as the two cannibalise one another over price.
The article states that “If you thought regulatory issues were the cannabis industry’s biggest challenges going into 2023, take a closer look at the price of raw marijuana flower. Retail and wholesale prices have fallen as competition with the black market puts pressure on legal retailers to keep prices low, and this is making it hard for growers to get the supply-demand balance right.”
“The industry today is facing a number of headwinds. The most existential is pricing,” said Rick Maturo, director of insights and intelligence for cannabis-data firm BDSA, during a webinar last week.
The retail price of a gram of marijuana dropped 13% to $9.43 in the third quarter of 2022 from $10.83 in the same period a year earlier — the steepest fall ever seen for marijuana in a 12-month period, according to BDSA. Wholesale price declines were even more dramatic, especially in more “mature” markets that have had legal programs for longer, BDSA data shows. In Colorado, the average price per pound has declined 51% since the fourth quarter of 2020. In Oregon, it’s down 36%.
While there is heavy competition for lower priced products in the legal market, and yes this is heavily influenced by the existence of the legacy market, the underlying cause for concern is still primarily cost of operations and licensing.
One also has to consider what the implications could be of an eventual globalised market where products from South America could be in play, where production can get as low as $0.50 a gram.
This also ignores the fact that in many established markets, high priced concentrates and true “premium bud” have continued to grow their overall market share and are slowly taking more and more sales away from low-cost bulk products. This is also an area of the legal market where the legacy market has difficulty competing due to the high quality nature of the extraction and grow facilities where these products are made which cannot be replicated or properly established in the legacy market.
A recent CBC article discussed how cannabis counter-culture has been impacted as “one of the oldest stores selling smoking paraphernalia in Ottawa, will be closing its doors for good in the spring.”
Mike Foster opened the head shop in Westboro in 1992 before moving to its location in the Glebe in 1997. The iconic cannabis counterculture store has been seen as an institution in the city.
Foster was involved in efforts to legalise cannabis because he said he didn't want to see people getting arrested for using the drug, but its legislation also led to the growth of larger retail operations catering to cannabis aficionados.
"The proliferation of cannabis shops certainly affected our sales on smoking accessories," he said.
"Once legalisation happened, our sales plummeted. There's so many stores out there now, like every few blocks there's a cannabis shop and you can buy your papers or pipes there. So that aspect of our business suffered."
Despite the challenges, Foster doesn't have any regrets about supporting legalisation efforts.
"I was still happy to see progress being made in that regard."
David Soberman, a professor of marketing at the Rotman School of Management at the University of Toronto, said stores like Crosstown Traffic have lost the "forbidden fruit appeal" they had when cannabis was prohibited.
Head shops had a "rebellious" nature that drew people in, Soberman said, working in the margins between legal and illegal.
"Legalisation kind of takes a bit of a romance out of the whole cannabis counter culture rebellion," Foster agreed.
What this article does not take into account however is that competition also exposes flaws. One of the aspects many legacy consumers have come to realise is that now that there are more options available, when it comes to aspects like inventory management, quality control, proper staffing, proper staff training and overall business functionality, many legacy stores and growers were underdelivering due to the lack of competition.
While legalisation has certainly changed the culture, if you want to maintain some of the counterculture aspects you can easily find examples of this aspect alive and well when you look at the heady glass scene in the US and Canada or the resurgence of psychedelics.
In order for cannabis to be able to compete with prescription medications as a medicine, which have lead to a corrupt medical system and a health epidemic in North America, or with alcohol as a social lubricant, which is one of the leading causes of domestic violence, emergency room calls and driving accidents, the culture has to change.
Cannabis for everyone, is in every way a positive move for the world. If you find yourself disheartened by the “taboo” factor of this plant being removed, then you have to ask yourself what was the culture you were really endorsing to begin with? Was it simply rebellion and uniqueness for their own sake, or was the goal from the start to get to a point where society returns to seeing cannabis as what it is, a plant that is extremely beneficial to humanity?
We all get upset when that obscure band we love suddenly has a hit that everyone knows and your secret club is ruined by a mass audience, but with cannabis, more access and a wider audience has the ability to change the overall culture in a positive way.
With both cannabis and psychedelics, once you have a truly potent experience, a part of you is changed, and changed mostly in a positive way. These plants still have the ability to teach all of us how to move into a less disastrous future, and so if we have to lose some of the “cool” factor, then that is a small price to pay for overall evolution.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
About Investorideas.com - Big Investing Ideas
We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders. Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water.
The Investorideas.com podcasts are also available on Apple Podcasts , Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts and most audio platforms available.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
New #Stocks and #Investor #TradingIdeas (CSE: $LEEF.C) (TSX: $PAY.TO) (CSE: $UDI.C)
New #Stocks and #Investor #TradingIdeas (CSE: $LEEF.C) (TSX: $PAY.TO) (CSE: $UDI.C)
#Cannabis, #Fintech and #Mining Stocks Added to Investor Ideas Free Stock Directories
Vancouver, Kelowna, Delta, BC, January 6, 2023 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Cannabis, Fintech and Mining. Today’s stocks have been added to our lists of free stock directories in each sector.
Read this in full at
The newest cannabis company is involved in extraction and manufacturing.
The latest fintech company works with payment solutions for employees and the latest mining company operated in British Columbia, Canada.
New Stocks added to the Cannabis Stocks List:
Leef Brands Inc. (CSE: LEEF) formerly Icanic Brands Company Inc. - is a leading California based extraction and manufacturing cannabis company. LEEF is owned and managed by some of the best legacy operators in the industry and is one of California’s largest and most sophisticated cannabis companies. Our platform consists of an integrated supply chain, state of the art manufacturing, industry leading brands, and a robust white labeling service offering that powers some of the largest brands in California. Our vision is simple and is centered around providing the end consumer with best-in-class products.
Leef Brands, Inc. is based in California, the largest cannabis market in the world. The Company’s mission is to build a great cannabis company with great people and great results.
New Stocks added to the Fintech Stocks List:
Payfare Inc. (TSX:PAY) is a global financial technology company powering digital banking and instant payment solutions for today's gig workforce. Payfare partners with leading platforms and marketplaces, such as Uber, Lyft and DoorDash, to provide financial health for their workforce.
New Stocks added to the Mining Stocks List:
Umdoni Exploration Inc. (CSE:UDI) is in the business of mineral exploration. The Company is focused on the exploration of its 100% owned Chlore Property (the “Property”) located near Smithers, BC. The Property hosts a calcalkalic porphyry copper-molybdenum target. In 2021 the Company’s work plan was focused on obtaining an understanding of the alteration and mineralization on the Property. The work program included helicopter borne magnetic and radiometric surveys over the whole Property area. The next phase of exploration on the Property will comprise geological mapping, soil and rock-chip sampling, and induced
polarization surveying in order to gain a detailed understanding of alteration and mineralization to define drill targets.
The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.
About Investorideas.com - Big Investing Ideas
We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders. Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water.
Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com
https://www.investorideas.com/Investors/Services.asp
Learn more about advertising and guest posts
https://www.investorideas.com/Advertise/
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Contact Investorideas.com
800 665 0411
Subscribe to:
Posts (Atom)
-
Investorideas.com - Cannabis Stock News: TransCanna (CSE: TCAN) Product Ranks in Leafly's Top Cannabis Strains List
-
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ...